Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Protein Design Labs grants patent license to Genentech

Nov. 16, 1998

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Nov. 16, 1998

AltaRex seeks permission to study immunological activity of OvaRex in phase II trial

Nov. 11, 1998

AltaRex moves to conduct clinical trial with OvaRex in more advanced ovarian cancer

Nov. 6, 1998

Adoptive immunotherapy of cancer with HSPs covered by U.S. patent

Nov. 4, 1998

Ribi ImmunoChem withdraws European Melacine application; focuses on U.S. and Canada

Nov. 3, 1998

FDA okays U.S. portion of multinational study evaluating Theratope

Nov. 2, 1998

Genentech begins shipping Herceptin to U.S. oncologists

Oct. 30, 1998

Positive initial clinical findings reported for first-generation GVAX vaccine for melanoma

Oct. 29, 1998

Positive efficacy and safety results reported for IDEC-Y2B8/Rituxan in NHL

Oct. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...